BLIMP-1, important for plasma cell differentiation [69], had B cell gene expression levels significantly increased in ERA patients in comparison with established RA under MTX treatment, which supports an activation of antibody secreting cells since early RA onset. This evidence concerns the gene PRDM1 and rheumatoid arthritis.